Literature DB >> 8814716

The value of Tc-99m MIBI SPECT during isosorbide dinitrate infusion in assessment of viable myocardium in patients with myocardial infarction.

S T Li1, X J Liu, Z L Lu, X D Zhu, R F Shi, Y J Yang, F Lu, W Q Chen, Q W Wu, Y Z Lu.   

Abstract

Tc-99m MIBI myocardial SPECT has shown promise for evaluation of coronary artery disease. But its role in predicting myocardial viability is still under investigation. The purpose of this study was to evaluate the value of Tc-99m MIBI myocardial SPECT during isosorbide dinitrate (ISDN) infusion in the assessment of myocardial viability. Thirty-seven patients with previous myocardial infarction (the infarct age ranged from < or = 30 days to 900 days) were studied, of them 13 patients had Tc-99m MIBI studies before and after coronary artery bypass grafting (CABG). The results showed that out of 134 segments with hypoperfusion at resting SPECT, 56 segments (41.8%) had an increase in Tc-99m MIBI uptake during ISDN infusion. Among them, 17 segments (30.4%) were normalized, 6 segments (10.7%) were significantly improved and 33 segments (58.9%) were improved. The degree of improvement in perfusion was related to the age of the myocardial infarction. In 13 patients with CABG, of 31 segments with improvement in perfusion post CABG, 25 segments (80.6%) showed perfusion improvement during ISDN infusion, and of 28 segments with improved wall motion post CABG, 23 segments (82.1%) showed improvement in perfusion during ISDN infusion. Tc-99m MIBI SPECT during ISDN infusion may therefore be a useful approach for assessing myocardial viability.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814716     DOI: 10.1007/bf03165049

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  19 in total

Review 1.  New Technetium 99m imaging agents: promising windows for myocardial perfusion and viability.

Authors:  P Liu
Journal:  Am J Card Imaging       Date:  1992-03

2.  Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease.

Authors:  C Altehoefer; H J Kaiser; R Dörr; C Feinendegen; I Beilin; R Uebis; U Buell
Journal:  Eur J Nucl Med       Date:  1992

3.  Relations of the myocardial imaging agents 99mTc-MIBI and 201T1 to myocardial blood flow in a canine model of myocardial ischemic insult.

Authors:  R C Canby; S Silber; G M Pohost
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

4.  Myocardial transport of hexakis(2-methoxyisobutylisonitrile) and thallium before and after coronary reperfusion.

Authors:  D J Meerdink; J A Leppo
Journal:  Circ Res       Date:  1990-06       Impact factor: 17.367

5.  Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT.

Authors:  Z X He; J Darcourt; A Guignier; E Ferrari; F Bussière; M Baudouy; P Morand
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

6.  Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.

Authors:  R Taillefer; R Lambert; R Essiambre; D C Phaneuf; J Léveillé
Journal:  J Nucl Med       Date:  1992-06       Impact factor: 10.057

7.  The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability.

Authors:  P Marzullo; G Sambuceti; O Parodi
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

8.  A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human.

Authors:  B L Holman; A G Jones; J Lister-James; A Davison; M J Abrams; J M Kirshenbaum; S S Tumeh; R J English
Journal:  J Nucl Med       Date:  1984-12       Impact factor: 10.057

9.  Clinical evaluation of 99Tcm-MIBI SPECT in the assessment of coronary artery disease.

Authors:  X J Liu; X B Wang; R L Gao; P Lu; Y Q Wang
Journal:  Nucl Med Commun       Date:  1992-10       Impact factor: 1.690

10.  Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging.

Authors:  A S Iskandrian; J Heo; B Kong; E Lyons; S Marsch
Journal:  Am J Cardiol       Date:  1989-08-01       Impact factor: 2.778

View more
  3 in total

1.  Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used?

Authors:  Z X He; M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

Review 2.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

3.  Nitrate-induced paradoxical ischemia predicts adverse outcomes in elderly patients with healed myocardial infarcts.

Authors:  Gian Piero Carboni
Journal:  Exp Clin Cardiol       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.